Home > Cardiology > AHA 2020 > Atrial Fibrillation > Active screening for AF improves clinical outcomes

Active screening for AF improves clinical outcomes

Presented By
Dr Steven Steinhubl, Scripps Research Translational Institute, USA
Conference
AHA 2020
Trial
mSToPS

The 3-year outcomes of the mHealth Screening to Prevent Strokes (mSToPS) trial demonstrated that active screening for atrial fibrillation (AF) by means of an ECG patch was associated with a significant improvement in clinical outcomes compared with standard-of-care controls, including a decrease in stroke and mortality risks [1].

AF is not only an independent risk factor for stroke but also for heart failure and cardiovascular mortality. Since AF is often not recognised until a serious clinical event occurs, earlier screening might result in better patient outcomes, Dr Steven Steinhubl (Scripps Research Translational Institute, USA) explained. The main objective of mSToPS (NCT02506244) was to determine if screening for AF by wearing a self-applied ECG patch can improve clinical outcomes at 3 years after the initiation of screening. The primary efficacy ou...



Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on